InMed Pharmaceuticals Q1 EPS $(0.36) Up From $(0.46) YoY
Benzinga Newsdesk 11 hours ago
NewsEarnings
InMed Pharmaceuticals (NASDAQ:INM) reported quarterly losses of $(0.36) per share. This is a 21.74 percent increase over losses of $(0.46) per share from the same period last year.
InMed Pharmaceuticals (NASDAQ:INM) reported quarterly losses of $(0.36) per share. This is a 21.74 percent increase over losses of $(0.46) per share from the same period last year.